Skip to main content

previous disabled Page of 50
and
Your search also matched 261 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

A non-invasive artificial intelligence model for identifying axillary pathological complete response to neoadjuvant chemotherapy in breast cancer: a secondary analysis to multicenter clinical trial

Include preview-only content
  1. Article

    Open Access

    Correction: Unveiling the role of HP1α-HDAC1-STAT1 axis as a therapeutic target for HP1α-positive intrahepatic cholangiocarcinoma

    Fei **ong, Da Wang, Wei **ong, **n Wang in Journal of Experimental & Clinical Cancer … (2024)

  2. Article

    Open Access

    Association of effective dose to immune cells and vertebral marrow dose with hematologic toxicity during neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma

    To explore the correlation between effective dose to immune cells (EDIC) and vertebral bone marrow dose and hematologic toxicity (HT) for esophageal squamous cell carcinoma (ESCC) during neoadjuvant chemoradio...

    Meng Zhang, Zhenjiang Li, Yong Yin in BMC Cancer (2024)

  3. Article

    Open Access

    Advances in spatial transcriptomics and its applications in cancer research

    Malignant tumors have increasing morbidity and high mortality, and their occurrence and development is a complicate process. The development of sequencing technologies enabled us to gain a better understanding...

    Yang **, Yuanli Zuo, Gang Li, Wenrong Liu, Yitong Pan, Ting Fan in Molecular Cancer (2024)

  4. Article

    Open Access

    Cell death shapes cancer immunity: spotlighting PANoptosis

    PANoptosis represents a novel type of programmed cell death (PCD) with distinctive features that incorporate elements of pyroptosis, apoptosis, and necroptosis. PANoptosis is governed by a newly discovered cyt...

    Lixia Gao, Chloe Shay, Yong Teng in Journal of Experimental & Clinical Cancer Research (2024)

  5. Article

    Open Access

    ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages

    Understanding the mechanisms that mediate the interaction between tumor and immune cells may provide therapeutic benefit to patients with cancer. The N6-methyladenosine (m6A) demethylase, ALKBH5 (alkB homolog ...

    **n Hua, Qiuli Xu, Ranpu Wu, Wei Sun in Journal of Experimental & Clinical Cancer … (2024)

  6. Article

    Open Access

    Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy

    Pediatric-type diffuse high-grade glioma (pHGG) is the most frequent malignant brain tumor in children and can be subclassified into multiple entities. Fusion genes activating the MET receptor tyrosine kinase ...

    Marc Zuckermann, Chen He, Jared Andrews, Aditi Bagchi in Molecular Cancer (2024)

  7. Article

    Open Access

    NSUN2/YBX1 promotes the progression of breast cancer by enhancing HGH1 mRNA stability through m5C methylation

    RNA m5C methylation has been extensively implicated in the occurrence and development of tumors. As the main methyltransferase, NSUN2 plays a crucial regulatory role across diverse tumor types. However, the preci...

    Xuran Zhang, Ke An, **n Ge, Yuanyuan Sun, **gyao Wei in Breast Cancer Research (2024)

  8. Article

    Open Access

    Transcriptomic and genomic characteristics of intrahepatic metastases of primary liver cancer

    Patients with primary multifocal hepatocellular carcinoma (HCC) have a poor prognosis and often experience a high rate of treatment failure. Multifocal HCC is mainly caused by intrahepatic metastasis (IM), and...

    Weilong Zou, Zhanjie Fang, Yu Feng, Shang** Gong, Ziqiang Li, Meng Li in BMC Cancer (2024)

  9. Article

    Open Access

    Unveiling the role of HP1α-HDAC1-STAT1 axis as a therapeutic target for HP1α-positive intrahepatic cholangiocarcinoma

    Intrahepatic cholangiocarcinoma (ICCA) is a heterogeneous group of malignant tumors characterized by high recurrence rate and poor prognosis. Heterochromatin Protein 1α (HP1α) is one of the most important nonh...

    Fei **ong, Da Wang, Wei **ong, **n Wang in Journal of Experimental & Clinical Cancer … (2024)

  10. Article

    Open Access

    A survey on brachytherapy training of gynecological cancer focusing on the competence of residents in China

    The brachytherapy is an indispensable treatment for gynecological tumors, but the quality and efficiency of brachytherapy training for residents is still unclear.

    Mohan Dong, Changhao Liu, Junfang Yan, Yong Zhu, Yutian Yin, Jia Wang in Radiation Oncology (2024)

  11. Article

    Open Access

    Minimal residual disease profiling predicts pathological complete response in esophageal squamous cell carcinoma

    Accurate presurgical prediction of pathological complete response (pCR) can guide treatment decisions, potentially avoiding unnecessary surgeries and improving the quality of life for cancer patients. We devel...

    Pinli Yue, Fenglong Bie, Jiarun Zhu, Lin-Rui Gao, Zhendiao Zhou in Molecular Cancer (2024)

  12. Article

    Open Access

    Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study

    To identify the risk factors of cervical high-grade squamous intraepithelial lesion(HSIL) complicated with occult cervical cancer and standardize the management of initial treatment for HSIL.

    Lingyu Lei, Lin Zhang, Yahong Zheng, Wei Ma, Fang Liu, Dongmei Li in BMC Cancer (2024)

  13. Article

    Open Access

    Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22–09

    Next-generation sequencing (NGS) has been introduced to many Korean institutions to support molecular diagnostics in cancer since 2017, when it became eligible for reimbursement by the National Health Insuranc...

    Sun Young Kim, Jee Hyun Kim, Tae-Yong Kim, Sook Ryun Park, Shinkyo Yoon in BMC Cancer (2024)

  14. Article

    Open Access

    Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells

    Dysregulation of immune surveillance is tightly linked to the development of metabolic dysfunction-associated steatohepatitis (MASH)-driven hepatocellular carcinoma (HCC); however, its underlying mechanisms re...

    Ying **e, Yu Huang, Zhi-Yong Li, Weihua Jiang, Nan-** Shi, Yuanzhi Lu in Molecular Cancer (2024)

  15. Article

    Open Access

    Does depressurization of the portal vein before liver transplantation affect the recurrence of HCC? A nested case-control study

    Portal hypertension (PHT) has been proven to be closely related to the development of hepatocellular carcinoma (HCC). Whether PHT before liver transplantation (LT) will affect the recurrence of HCC is not clear.

    Guo Wei, Yong Zhao, Shifeng Feng, **gsheng Yuan, Gang Xu, Tao Lv, Jian Yang in BMC Cancer (2024)

  16. Article

    Open Access

    Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective study

    This study compared the prevalences of metabolic syndrome and of cardiac or kidney comorbidities among patients with hepatocellular carcinoma (HCC) associated with metabolic dysfunction-related fatty liver dis...

    Da-Long Yang, Shao-** Liu, Hong-Liang Wang, Jian-Rong Li in Infectious Agents and Cancer (2024)

  17. Article

    Open Access

    Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistance

    CDC6 is an oncogenic protein whose expression level fluctuates during the cell cycle. Although several E3 ubiquitin ligases responsible for the ubiquitin-mediated proteolysis of CDC6 have been identified, the ...

    Jianfeng Cui, **aochen Liu, Qinghong Shang, Shuna Sun, Shouzhen Chen in Molecular Cancer (2024)

  18. Article

    Open Access

    HIST3H2A promotes the progression of prostate cancer through inhibiting cell necroptosis

    In recent years, there has been an increase in the incidence and mortality rates of prostate cancer (PCa). However, the specific molecular mechanisms underlying its occurrence and development remain unclear, n...

    Lihong Yang, Yong Ruan, Houqiang Xu in BMC Cancer (2024)

  19. Article

    Open Access

    Systematic optimization and evaluation of culture conditions for the construction of circulating tumor cell clusters using breast cancer cell lines

    Circulating tumor cell (CTC) clusters play a critical role in carcinoma metastasis. However, the rarity of CTC clusters and the limitations of capture techniques have retarded the research progress. In vitro C...

    Jueyao Zou, Qiong Chen, Yong He, Yanhong Pan, Han Zhao, Junfeng Shi in BMC Cancer (2024)

  20. Article

    Open Access

    PSAT1 enhances the efficacy of the prognosis estimation nomogram model in stage-based clear cell renal cell carcinoma

    Clear cell renal cell carcinoma (ccRCC) is associated with a high prevalence of cancer-related deaths. The survival rates of patients are significantly lower in late-stage ccRCC than in early-stage ccRCC, due ...

    Jun Wang, **aoming He, Yuanyuan Mi, Yong Q. Chen, Jie Li, Rong Wang in BMC Cancer (2024)

previous disabled Page of 50